US Pharma MarketingBD called completing enrollment in the study “a significant milestone in its advanced tissue regeneration strategy and expansion efforts.”
BD fully enrolls trial of resorbable mesh for hernia prevention
BD fully enrolls trial of resorbable mesh for hernia prevention is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive